UK Drug Discovery Informatics Market Reaches $242.2 Million in 2025 with 7.6% CAGR

UK drug discovery informatics market was valued at $242.2 million in 2025 and is projected to reach $502.1 million by 2035, growing at a CAGR of 7.6% during the forecast period (2026–2035). Drug discovery informatics in the UK involves the application of computational modeling, virtual screening, molecular docking, data integration, and advanced analytics to support drug discovery and development, including target identification, lead optimization, and library and database management. The market is experiencing steady growth, supported by the UK’s strong pharmaceutical and biotechnology ecosystem, world-class academic research institutions, and well-established contract research organizations (CROs). Increasing public and private investment in life sciences R&D, along with national initiatives to advance data-driven healthcare and biomedical innovation, is strengthening the adoption of informatics platforms across the country. Key trends shaping the UK drug discovery informatics landscape include the growing use of artificial intelligence and machine learning to accelerate hit discovery and improve prediction accuracy, expanding adoption of cloud-based and high-performance computing environments, and increasing utilization of large-scale chemical, genomic, and real-world data to reduce development timelines and costs. Collaboration between academia, biotech startups, and global pharmaceutical companies continues to play a critical role in advancing informatics-driven drug discovery in the UK.

Browse the full report description of “UK Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/uk-drug-discovery-informatics-market

According to EMBL-EBI, Genomics England, and the Office for National Statistics (ONS), the United Kingdom has established a robust drug discovery informatics ecosystem supported by large-scale genomic sequencing programs, globally used bioinformatics databases, and a strong life-sciences workforce. Publicly funded data platforms and national research initiatives are accelerating the adoption of computational tools such as molecular modeling, docking, sequencing and target data analysis, and compound library preparation across pharmaceutical companies, biotechnology firms, and contract research organizations.

Key Innovators Driving UK Drug Discovery Informatics Transformation

The key players in the UK drug discovery informatics market include Accenture plc, Clarivate Plc, Dassault Systèmes SE, Illumina, Inc., Thermo Fisher Scientific Inc., among others. These companies are driving innovation through AI-enabled modeling and simulation platforms, integrated informatics solutions, and scalable cloud technologies, shaping the future of drug discovery and pharmaceutical research in the United Kingdom.

• In June 2025, the UK-based OpenBind Consortium was launched with the objective of positioning the UK as a global leader in AI-driven drug discovery. The initiative aims to create the world’s largest drug–protein interaction dataset approximately 20 times larger than any previously available public dataset to enable the training of advanced AI models for drug design.
• In July 2024, Exscientia expanded its UK footprint by introducing a cloud-based drug discovery platform in collaboration with AWS. The platform combines generative AI for molecular design with automated synthesis and testing, supporting an integrated end-to-end “design–make–test–learn” workflow.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Function
  • By End-Users
• Competitive Landscape - Accenture plc, Clarivate Plc, Dassault Systèmes SE, Illumina, Inc., Thermo Fisher Scientific Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

UK Drug Discovery Informatics Market Report Segment

By Function

• Docking
• Molecular Modeling
• Libraries & Database Preparation
• Sequencing & Target Data Analysis
• Others

By End-Users

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Others

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/uk-drug-discovery-informatics-market